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We provide here an historical perspective of NMR applied to iron-containing proteins. At first, 
the field developed using paramagnetic NMR: the 1H-NMR spectra of heme and FeS proteins 
were used as clear spectroscopic fingerprints of the electronic structure of the metal ion and its 
inner and outer coordination spheres. Starting 1994, NMR of metalloproteins was focused more 
on the protein part and the determination of the 3D structures in solution of small proteins was 
achieved; paramagnetic NMR observables were exploited as non-conventional NMR 
constraints. With time, NMR has gained attention as a methodology to monitor protein-protein 
interactions, becoming a unique tool to learn about the interaction surfaces in weak transient 
complexes. The recent interest in the understanding of metal ion homeostatis and metal 
cofactor assembly has led to a renewed interest in the application of NMR: i) as a spectroscopic 
tool, to characterize the novel binding site of metal centers where the metal is no more an 
integral part of the protein but rather a chemical entity that has to be transferred along 
trafficking pathways or a cofactor that has to undergo specific reactions; ii) as a structural 
method for the definition of the metal-mediated protein-protein interactions. The reported 
case examples cover the bacterial heme acquisition system, the cytosolic FeS protein assembly 
and mitochondrial FeS clusters assembly machineries and the eukaryotic iron-storage ferritin. 
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Abbreviations: FeS, iron-sulfur; CS, contact shift; PCS, pseudocontact shift; RDCpara, 
paramagnetic residual dipolar coupling; CCR, cross correlation; Rdx, rubredoxin; NOE, nuclear 
Overhauser effect; COSY, correlation spectroscopy, NOESY, nuclear Overhauser effect 
spectroscopy; HiPIP, high potential iron-sulfur protein; SOD, superoxide dismutase; MW, 
molecular weight; HSQC, heteronuclear single-quantum correlation; HaS, heme acquisition 
system; CRINEPT, cross-correlated relaxation-enhanced polarization transfer; TROSY, transverse 
relaxation-optimized spectroscopy; CIA, cytosolic iron–sulfur protein assembly; FMN, flavin 
mononucleotide; Grx, glutaredoxin; ISCA, iron-sulfur cluster assembly protein; PCBP, human 




1. Introduction  
Iron is essential to virtually all living organism where it’s found tightly coordinated in a variety 
of protein active centers with different functions [1,2]. A crucial distinction is traditionally made 
between heme and non-heme iron proteins. In heme proteins, iron is stably bound to the 
porphyrin macrocycle and its coordination sphere is completed by one or two axial ligands; first 
and second coordination sphere residues modulate function as well as redox and spin states 
[3]. A bioinformatic analysis of the available structures for non-heme iron-proteins published in 
2009 [1] showed that the entire ensemble of non-heme iron proteins in the Protein Data Bank 
accounts for 86 distinct Fe-sites, more than 50% of which correspond to iron–sulfur centers and 
about one third to mononuclear centers, the remaining were found to be dinuclear sites, with 
the only exception of a polynuclear site.  
Historically, NMR has contributed to the characterization of two large subsets of iron-proteins: 
heme and iron sulfur proteins. In all these cases the iron was an integral part of the protein and 
played a key role for the activity. 
To our knowledge, the first spectrum of a heme protein dates back to 1962, when Kowalski [4] 
published low resolution NMR data on oxidized and reduced horse hearth cytochrome c. Based 
on the consideration that the ferric cytochrome is paramagnetic and the ferrous form is 
diamagnetic, he proposed that “differences in these spectra arise from the change in magnetic 
properties of the iron”. In the same years the bases of paramagnetic NMR were established, 
leading to a well-developed theory that is extensively covered by several books and reviews 
[5,6,7,8,9,10]; the key concepts and equations are summarized in Section 1.1.  
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With the exception of low spin iron(II) heme systems, where the large ring current effects 
produced by the porphyrin macrocycle permit to resolve some of the heme signals outside the 
diamagnetic envelope, the NMR characterization of iron sites in proteins has been focused on  
paramagnetic species by exploiting the structural information embedded in the observables 
which depend on the unpaired electron(s)-nuclear coupling [9].  
 
1.1 Paramagnetic NMR 
Nuclei interact with unpaired electrons of metal ions through two main mechanisms: a through-
bond contact interaction and a through-space dipolar interaction, which translate into 1) an 
extra contribution to the nuclear chemical shift (called the hyperfine shift) that adds, with a 
positive or negative sign, to the diamagnetic shift and 2) a reduction of the nuclear relaxation 
times [6,11,12,13,14].  
1.1.1 Hyperfine shift The hyperfine shift can be estimated by subtracting from the observed 
shift of the paramagnetic molecule the one measured for a diamagnetic analog. The hyperfine 
shift is the result of the contact and pseudocontact terms. The relative importance of the two 
contributions depends on the electronic structure of the paramagnetic metal and on the 
position of the observed nucleus with respect to the metal center. 
The contact shift (CS) is the through-bond contribution to the hyperfine shift of a nucleus 
and is proportional to the unpaired electron spin density on the nucleus itself which occurs 
through direct spin delocalization and/or spin polarization, as expressed by the following Eq. 1. 
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As such, it’s different from zero only for the nuclei of the ligands of the paramagnetic metal 












          (1) 
where A is the hyperfine coupling constant, which is proportional to the electron spin density at 
the nucleus and can be anisotropic due to electron orbital contributions; g  is the average g 
value along the principal directions of the contact coupling, when the latter is anisotropic, B  is 
the electron Bohr magneton; S is the electron spin number; I  is the gyromagnetic ratio of a 
generic I nucleus; k is the Boltzmann constant; T is the absolute temperature. Hybrid density 
functional calculations have been used to predict contact shifts for  1H, 2H and 13C spins, in 
order to confirm NMR assignments and to assess the reliability of calculated spin densities [16]. 
CS was observed also as the result of unpaired spin delocalization occurring via H-bonds [17].  
The pseudocontact shift (PCS) originates from the through space, dipolar coupling of the 
unpaired electron spin with the nuclear spin [18,19]. If the electron magnetic moment is 
anisotropic (i.e. it has non zero magnetic susceptibility anisotropy), the electron-nuclear dipolar 
coupling does not average to zero with molecular tumbling in solution and yields a shift that is 
dependent on both the electron-nucleus distance and the orientation of the electron-nucleus 
vector with respect to the magnetic susceptibility tensor (Eq. 2). In practice, the mechanism is 
effective on all the nuclei within a certain distance from the anisotropic paramagnetic metal 
center and at an appropriate angular position with respect to the magnetic anisotropy tensor 
axes. PCS is proportional to the inverse third power of the electron-nucleus distance, in the 
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approximation that the unpaired electron spin density is all metal centered. Given its 
dependence on distance and angular parameters, PCS provides information on the spatial 
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rh are the 
axial and rhombic components of the anisotropic magnetic susceptibility tensor; MH  and MH  
are the polar angles of the nucleus H with respect to the principal axes of the magnetic 
susceptibility anisotropy tensor in a reference system that has M in its origin. 
1.1.2 Paramagnetic relaxation Coupling between unpaired electron spin(s) and nuclear spins 
provides them relaxation mechanisms that make nuclear relaxation more efficient, with 
consequent shortening of longitudinal and transverse relaxation times (T1 and T2) [13]. The 
paramagnetic contributions to the nuclear T1 and T2 arise from essentially three different 
sources: 
i) The contact interaction, due to delocalized electron spin density and therefore confined 
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ii) The electron-nuclear dipolar interaction that, in a metal centered approximation, 
depends upon the inverse sixth power of the nucleus-iron distance (Eqs. 5 and 6) 
[21]. When electron spin density is delocalized on the ligand, metal centered 
approximation does not hold anymore and deviations from Eqs. 5-6 ma be 
significant. As a general criterion, it has been proposed that only protons farther 
than four  bonds, farther than 0.5 nm and not involved in H-bonds to the metal 
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iii) The Curie spin interaction, arising from the interaction between the nuclear spin and the 
large time-averaged magnetic moment of the electron [22,23]. It also depends upon 
the inverse sixth power of the metal-nucleus distance. The contribution of this 
relaxation mechanism to T1 is negligible, instead the contribution to T2 becomes 
dominant at high molecular weights, highly paramagnetic systems and at high 
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In equations 3-7, the not-yet defined symbols are: I and S , the Larmor frequencies of 
the nuclear and electron spins I and S, respectively; I , the gyromagnetic ratio of a generic I 
nucleus; ge is the free electron g value. The correlation time for the interactions contributing to 
the relaxation is indicated by c. and represents the result of various dynamic factors 
modulating the nuclear-electron spin interaction, each of them characterized by its own 
correlation time. The relaxation process with the shortest   becomes dominant, as indicated in 
Eq. 8: 
1111   Mrsc            (8) 
where s is the electron relaxation correlation time, r  is the rotational correlation time and 
M  is the exchange correlation time that is operative only in the presence of chemical or 
conformational equilibria. Although in all the equations the same symbol (c) has been used, in 
the case of contact relaxation (Eqs. 3-4), only chemical exchange (M) and electron relaxation 
(s) can modulate the coupling between the electron and the nucleus; in the case of dipolar 
relaxation (Eqs. 5-6) also the rotational correlation time can modulate the interaction. In Curies 
spin relaxation (Eq. 7), only chemical exchange (M) and rotational correlation (r) are effective.  
With the advent of high-field NMR spectrometers new paramagnetic effects have become 
observable and measurable. 
All molecules with molecular magnetic susceptibility anisotropy (mol) different from zero adopt 
preferred orientations in an external magnetic field. The orientation of the molecules in 
solution follows a Boltzmann distribution and the degree of alignment is proportional to the 
applied field [24]. This partial alignment gives rise to observable effects in the NMR spectra of 
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proteins that can be quantified by suitably designed experiments and amplified by addition of 
orienting media [25]. Among the observables originating from the partial orientation, the non-
completely averaged, i.e. residual, dipolar couplings (RDCs) [26,27] are an important source of 
information. In paramagnetic proteins, when the metal center has non zero magnetic 
susceptibility anisotropy the molecular magnetic susceptibility is dominated by the 
paramagnetic contribution (para), which is the same magnetic susceptibility responsible of 
PCS’s. As reported in Eq. 9 for the case of the 15N of backbone amide and its attached proton, 
the paramagnetic residual dipolar coupling (RDCpara) for a pair of nuclei depends on the 
orientation of the vector connecting the two nuclei with respect to the magnetic susceptibility 
































where NHr is the distance between the amide proton and the amide nitrogen and is generally 
considered fixed; NH  and NH  are the polar angles that describe the orientation of the 
internuclear N-H vector with respect to the alignment tensor; N  and H  are the gyromagnetic 
ratios of 15N and 1H, respectively;  B0 is the external magnetic field. All the other symbols have 
the usual meanings. 
Cross correlation (CCR) between the internuclear dipolar relaxation and Curie relaxation (see 
above) causes differential line broadening effects [28,29,30,31,32,33]. In the case of a backbone 
amide H-N doublet, the effect measured on the 1H spins depends upon the angle between the 
H-N vector and the H-metal vector and upon the inverse third power of the distance between 
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the proton and the metal ion and the inverse third power of the distance between the amide 


















































  (10) 
Here the only new symbol is CCR  i.e., the angle between the metal-proton vector and the N-H 
vector. 
1.2 NMR of Iron Proteins: an historical perspective.   
Besides mononuclear low spin iron(II), all the other iron centers in proteins are 
paramagnetic, therefore the use of NMR for the characterization of iron proteins has followed 
over the years the instrumental and methodological developments of paramagnetic NMR. In 
the quest for a paradigmatic “test” system to address the properties of the hyperfine 
interaction, heme proteins and Iron-Sulfur proteins have been frequently used. Indeed from the 
spectroscopic view point, proteins from these two classes are complementary. In heme 
proteins, the high magnetic anisotropy is such that PCS (Eq. 2) and RDC (Eq. 9) can be extremely 
informative and indeed, they provide a number of information that can be exploited to obtain 
structural information (see Section 1.2.2). In FeS proteins, the electron distribution within the 
cluster is such that the magnetic anisotropy is negligible essentially in all cases. Negligible PCSs 
remove the problem of factorization between CS and PCS; this has been used to interpret, for 
nuclei of iron-bound Cys residues, CS contributions in terms of dihedral angle dependence from 
the dihedral angle Fe-S-C-H, on the basis of a Karplus-type relationship [34]. In both cases, the 
systems studied for decades were proteins were the iron cofactor was an integral part of the 
functional form. It is intriguing how, these proteins acted as model systems for more 
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complicated cases in which transient sites, conformational flexibility, protein-protein 
interactions complicate the investigation and stimulate, on one hand new methodological 
development but, on the other hand, the revival of “old” NMR approaches. 
1.2.1 Enlightening the metal center. In metalloproteins, NMR signals affected by the 
interaction with a paramagnetic center can be selectively observed outside the diamagnetic 
envelope thanks to the hyperfine shift contribution (Eqs. 1 and 2). Typically, the experimental 
strategy for their observation requires the acquisition of spectra over large spectral windows 
using fast repetition times, which can be used because of reduced T1 values (Eqs. 3 and 5) 
[35,36]. The reduction in T2 (Eqs. 4, 6 and 7) may cause severe signal broadening and a large 
number of scans is needed to obtain an acceptable S/N ratio; moreover, signals that are most 
affected by the paramagnetic center can be broadened beyond detection. According to Eq. 7, 
the effect is enhanced by the use of high magnetic fields for large molecular weight systems 
and for systems with high electron spin S values.  
The extent of paramagnetic broadening depends upon the nature of the iron center: those with 
the longest electron relaxation times, s , cause (Eq. 8) the largest reduction in nuclear 
relaxation times T1 and T2 [8,13]. In this frame, iron is the most versatile among all transition 
metal ions: high spin iron(III) (S=5/2) is one of the most unfavorable ions, having electron 
relaxation times in the range 10-9 – 10-11 s, whereas those of low spin iron(III) (S=1/2) and high 
spin iron(II) (S=2) are of the order of 10-11 – 10-13 s [37]. Low spin heme iron(III) can be 
considered as one of the most suitable systems to be studied via paramagnetic NMR because of 
its particularly favorable s  of the order of 10
-12 s.  
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The versatility of iron sites in proteins, in terms of electronic properties, oxidation states and 
coordination chemistry is enhanced by iron ability to form FeS clusters (Fe2S2, Fe3S4, Fe4S4), 
each of them being available in at least two distinct oxidation states [38,39,40,41]. Within FeS 
clusters in proteins, iron ions are almost invariantly in a tetrahedral coordination environment 
provided by two or three inorganic sulfides from the cluster and by one or two sulfur atoms 
from Cys coordinating residues. Only in the case of Rieske proteins the iron ions of a Fe2S2 
cluster have asymmetric coordination environments because one of the two iron ions is bound 
by imidazole N1 atoms of two His residues to form a characteristic Fe(N2S2) tetrahedral 
coordination [42,43,44,45].  
In FeS proteins, the electron relaxation time and the spin state of each individual iron ion 
depends on the magnetic couplings established among iron ions within the FeS cluster and may 
be substantially different from what expected in the case of Rubredoxins (Rdx), which contain a 
single Fe3+/2+ iron ion bound to four Cys residues in a tetrahedral coordination geometry. 
Although Rdx’s do not contain a FeS cluster nor inorganic sulfur ligands, they are typically 
considered within the family of FeS proteins. Both iron(III) and iron(II) ions show, in the 
tetrahedral coordination of Rdx’s, long electron relaxation times (ca. 10-9 s for iron(III) and ca. 
10-11s for iron(II)) and indeed 1H signals from Cys coordinating residues could be observed only 
in the reduced state at low magnetic field, i.e., under conditions where the Curie term (Eq. 7) is 
smaller [46]. Rubredoxins represent a nice example on how the direct detection of low γ nuclei 
such as 13C and 15N may help to characterize paramagnetic centers in proteins. According to 
Eqs. 6 and 7, paramagnetic relaxation depends on γ2. When iron-coordinated cysteines are 
undetectable via 1H NMR spectroscopy because signals are broadened beyond detection, then 
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low  (13C, 15N and even 2H) NMR spectroscopy provides extensive assignments for resonances 
of metal bound residues [47,48,49] (for the advantages of heteronuclear detection in 
paramagnetic proteins  see also section 3.1 and related references).  
The magnetic exchange coupling between iron ions in FeS clusters gives rise to paramagnetic 
centers in which electron relaxation times are always shorter than those of isolated iron ions 
and new energy levels arise from the combination of the individual S spin states [50,51,52]. The 
extent of magnetic exchange coupling substantially affects observable NMR parameters [53]. 
For [Fe2S2] containing proteins, in the oxidized state [Fe2S2]
2+, the two iron(III) ions are 
antiferromagnetically coupled to give a S=0 electronic ground state. Due to the population of 
excited states of the spin ladder, the protein is paramagnetic at room temperature [50]. 
Because paramagnetism increases at increasing temperature, hyperfine shifts have a behavior 
opposed to what expected on the basis of Eq. 1, defined as anti-Curie behavior. The reduced 
state [Fe2S2]
+ , is formally constituted by two iron(III) and one extra electron, for which the 
localization is driven by the protein environment  [54]. In plant-type and human ferredoxins the 
extra electron is localized and the systems are constituted by one iron(III) and one iron(II) [54] 
[53]; however delocalized valence was proposed for the bacterial [Fe2S2]
 ferredoxin from C. 
pasteurianum [55] and has been recently observed for the human [Fe2S2] protein anamorsin 
[56].  
For [Fe4S4] containing proteins, Nature has designed different protein scaffolds that were able 
to stabilize two out of three possible electronic states: [Fe4S4]
3+, [Fe4S4]
2+, [Fe4S4]
+. The acronym 
HiPIP (High potential Iron-sulfur Proteins) is used to indicate bacterial proteins in which the 
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cluster switches between [Fe4S4]
3+/2+ , while low potential proteins (ferredoxins) switches 
between [Fe4S4]
2+/+. In the [Fe4S4]
2+ state, all these systems show a completely delocalized 
valence in which each iron ion is formally Fe2.5+ [57] . The iron ions are pairwise coupled, and 
give  two subspins S=9/2, which are then antiferromagentically coupled to obtain S=0 ground 
state [58], thus providing a situation similar to what already described in the [Fe2S2]
2+ case [50]. 
Indeed, both [Fe2S2]
2+ and [Fe4S4]
2+ proteins are EPR silent and have NMR signals with antiCurie 
behavior [58]. In the [Fe4S4]
+, state, one of the two iron pair accept the extra electron and 
become a ferrous pair (S=4). The overall S=1/2 ground state is therefore described as the result 
of the antiferromagnetic coupling between a mixed valence ion pair with S=9/2 and a pure 
ferric pair with S=4 [34,59]. 
A similar behavior is observed in the [Fe4S4]
3+, state, in which one of the two mixed valence pair 
of the [Fe4S4]
2+ state loose and electron and become a pure ferric pair [60]. Several HiPIPs have 
been isolated from photosynthetic bacteria and this has allowed to demonstrate that: i) the 
iron ion pair delivering the electron when passing from [Fe4S4]
2+ to [Fe4S4]
3+ is not always the 
same on passing from one HiPIP to another, ii) an equilibrium between two different electronic 
distributions occurs among all HiPIP [51,61,62,63,64,65,66,67,68]. Overall, HiPIPs provide a 
demonstration that the electronic properties of the FeS clusters are modulated by the protein 
environment. Structural differences around the cluster observed even for highly homologous 
proteins drive the individual oxidation state of each iron ions of the cluster [51,69]. The redox 
state of the cluster regulates also the thermodynamic stability and triggers protein [70,71]  
1H NMR spectra of FeS proteins typically gives rise to spectra in which CH2 and CH protons 
from Cys residues experience shifts in the range +100/-50 ppm, entirely arising from contact 
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contributions and, in some case, depend on the Fe-S-C-H dihedral angle [34]. However, both 
shift and relaxation vary along the various FeS cluster. For example, a [Fe4S4]
3+ cluster is a very 
favorable systems to be characterized via paramagnetic NMR while a [Fe2S2]
2+ gives rise to 
much broader NMR lines[39]. 
Extensive NMR characterization is also available for [Fe3S4]
+ proteins [72,73,74]. The formal 
symmetry of the system,  made by three Fe3+ ions, is broken by magnetic coupling: two iron(III) 
ions couple to obtain a S=2 subspin, the antiferromagnetic coupling between the S=2 pair and 
an isolated S=5/2 iron(III) gives a total S=1/2 ground state [75,76]. Paramagnetic NMR showed 
that the Fe3+ ion that remains isolated is not always the same. Like the [Fe4S4] case, structural 
factors drive the magnetic coupling scheme [77]. 
Among mononuclear, non heme, iron sites in proteins that have been studied by NMR, the case 
of Fe superoxide dismutase (FeSOD) shows how the electron relaxation time of the metal ion is 
finely tuned by its coordination number. Indeed, iron(III) in the active site of FeSOD is 
coordinated in a trigonal bipyramid by two His and an Asp in the equatorial plane and by an His 
and a H2O molecule in the axial positions. In the reduced, iron(II) form, relatively nice NMR 
spectra, compared to the case of tetracoordinated iron(II) in Rdx, can be collected, due to the 
shorter electron relaxation time of pentacoordinated iron(II) with respect to tetracoordinated 
[78,79]. Paramagnetic NMR also permitted to monitor a structural change in the active site of a 
tetrameric form of FeSOD (MW about 100 kDa), using variable temperature NMR [80]. 
In the case of heme proteins, the 1H heme methyls chemical shift patterns (that arise from a 
combination of contact and pseudocontact contributions) have soon revealed to constitute a 
fingerprint of the spin state in iron(III) hemes, allowing a clear discrimination between low spin 
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(S=1/2) and high spin (S=5/2) spin states, as well as to unravel the presence of intermediate 
spin form or of spin-admixtures [9]; meso 1H chemical shifts were proposed as probes of the 
presence of water in the sixth coordination position of iron(III) hemes [81]. Signals of axial 
ligands in high spin heme iron(III) were generally undetectable (with the exception of the N1 
of the proximal His), while they could be observed in the low spin state. The spectra of high spin 
iron(II) are characterized by less resolved features and therefore most of the research focused 
on the iron(III) systems, in particular peroxidases in their high spin resting state, metmyoglobin, 
ferric P450, chlorins and some of their low spin cyanide adducts, ferric cytochromes and spin 
admixed/intermediate spin cytochromes c’. For an extensive review of this work refer to [9]. 
The interpretation of the spin delocalization patterns on the porphyrin ring is not trivial and 
Hückel and density functional theory (DFT) calculations have been employed to this purpose 
[82,83,84]; in addition, semiempirical equations have been developed for specific combinations 
of axial ligands in low spin iron(III) heme proteins [85,86] that allow to establish a correlation 
between chemical shift patterns and axial ligand geometries.  
Development of 1D NOE and 2D 1H-1H COSY and NOESY experiments 
[87,88,89,90,88,91,92,93,94,95,96,97,95] lead to specific assignments of the resonances of 
heme substituents, of axial ligands (for low spin systems) and of other residues in the heme 
cavity. These methodological developments in paramagnetic NMR revealed important 
structure-function relationships: a clear correlation between reduction potential of the heme 
iron centers and electronic properties modulated via second coordination-sphere effects was 
established [88,90,98,99,100,101,102], the role of the heme peripheral residues in modulating 
heme binding preferences was unraveled [88,90,103,104,105,106], mutation of residues in the 
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distal and proximal cavity helped understanding the role of the conserved amino acids 
[88,90,100,107,108], the location of small-molecule substrates was identified shading light on 
the reaction mechanisms [109].  
1.2.2 NMR-based solution structures. The first solution structure of a paramagnetic protein 
was that of the reduced, [Fe4S4]
2+ form of HiPIP I from Ectothiorhodospira halophila (Fig. 1) 
[110,111], solved in 1994 i.e, 10 years after the first application of NMR as a tool for structure 
determination of diamagnetic proteins [112]. This achievement contradicted common believes 
[113] that complete solution structures of paramagnetic proteins were not feasible due to the 
undetectability of residues in the surrounding of the metal; the previous experience in 
characterizing paramagnetic metal centers in proteins, as described in 1.2.1, was essential to 
accomplish this goal. This first structure was the beginning of a new era, during which the 
structure determination of paramagnetic proteins was pursued. These had two major 
consequences: to move the focus of bioinorganic NMR to smaller proteins such as electron 
transfer iron-sulfur and cytochromes and to stimulate researchers to exploit the structural 
information embedded in NMR paramagnetic parameters (see equations 1-10) to derive new 
structural restraints [10,114].  
Among the quantities expressed in Eqs. 1-8 and 10, only PCS, RDCpara, CCR, the dipolar term 
of T1 and the dipolar and Curie terms of T2 contain an explicit dependence upon structural 
parameters such as distances and angles. Different paramagnetic-based NMR restraints have 
been exploited to refine the structure of different iron proteins, depending  on the electronic 
properties of the metal center. 
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In the case of FeS proteins, the use of relaxation based-constrains was pursued. For 1H 
nuclei close to the paramagnetic center, longitudinal relaxation rates are dominated by the 
term described in Eq. (5) which contains a r-6 dependence from the metal-to-nucleus distance 
and can, therefore, be used as a metal-to-proton structural constraint. T1 based restraints were 
used to refine the structure of the HiPIP I from E. halophila [115,116] and turned out to be 
especially relevant in the case of small ferredoxins containing two [Fe4S4]
2+ clusters [117,118]. 
Indeed, even if the r-6 dependence is such that the T1 based restraints act as short-distance 
restraints, which usually affect a limited number of protons, in the latter case the small protein 
size and the presence of two clusters cause a significant percentage of 1H spins experiencing 
paramagnetic relaxation and therefore the protein structure was substantially improved by the 
use of relaxation-based NMR constraints. To account for the electron delocalization within the 
cluster, for each measured T1 value, the distance to the closest iron ion was considered, and an 
upper limit value of 5 s-1 was considered as diamagnetic contribution to obtain, from the 
experimental T1 values, the paramagnetic contribution of Eq. 5 [118].  
FeS clusters have a negligible magnetic susceptibility anisotropy and, therefore, relaxation 
based NMR constraints are the only source of paramagnetic restraints to be possibly exploited. 
The situation is different in the case of low spin iron(III) paramagnetic heme proteins, where 
NMR permits to estimate the magnetic susceptibility anisotropy and the principal directions of 
the magnetic susceptibility tensor axes using the hyperfine shift values measured for the nuclei 
surrounding the heme, with the exception of those of the coordinating groups [119,120]. In 
these systems, PCSs (Eq. 2) have been introduced for the first time as non-conventional 
restraints that complement NOE-based upper distance limits for solution structure 
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determination (Fig. 2) and used also for the refinement of available crystal structures 
[121,122,123,124] Later, the measure of PCSs for tens of nuclei (including 15N for backbone 
amides) has allowed an accurate estimate of the magnetic anisotropy parameters in 
deoxymyoglobin and reduced cytochrome c’ (both high spin iron(II)) [125,126], and in 
metmyoglobin (high spin iron(III)) [29]. 
The NMR solution structure determination of paramagnetic metalloproteins with a 
resolution around the paramagnetic center that is comparable to that of their diamagnetic 
analogues has allowed to study of the structural changes that accompany variations in the 
redox state of Iron-sulfur clusters and of heme iron in cytochromes and can be related to the 
reorganization energy of the electron transfer process 
[115,122,123,124,127,128,129,130,131,132,133]. The initial steps of the structural biology of 
heme and iron-sulfur proteins have been reviewed [39,134,135]. 
In addition to T1 and PCS, other paramagnetic non-conventional restraints can be derived, 
which are based on effects detectable only at high magnetic fields. Paramagnetic RDCs (Eq. 9) 
are constraints that arise from self-orientation induced by a magnetically anisotropic 
paramagnetic center. As this effect does not depend on the hyperfine interaction but only 
depends on magnetic anisotropy generated by the metal ions, RDCpara’s do not depend at all on 
the metal-nucleus distance and therefore they are able to provide additional structure 
information throughout the entire protein. Initially demonstrated in the case of cyano 
metmyoglobin [26], RDCpara’s have been successfully used to refine a large number of other 
heme proteins, which are invariantly characterized by the presence of strong magnetic 
anisotropy [26,29,125,136,137,138]. Internal protein motions on the ps to ms time scale can 
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strongly affect the results: in the presence of internal dynamics the measured RDC values are 
smaller than expected for a rigid protein with the same structure because they result from the 
average of all the conformations spanned by the protein in the mentioned time scales. As 
demonstrated for the alkaline form of cytochrome c [136], in the presence of this type of 
motions, RDCpara’s are no more useful as structural restraints, but their measure provides 
information on the dynamics of the system. The use of CCR (Eq. 10), instead is of potential 
interested but for the moment its use in heme proteins remains a mere exercise [139]. 
 
2. Structural biology of iron trafficking. What has been described in the previous Sections 
summarizes the use of NMR for the characterization of the structure of iron-containing proteins 
in their isolated forms. More recently, NMR has gained importance as a tool to study 
interactions involving biological macromolecules. Among the several protein interactions of 
biological relevance, a large share is composed by the network of protein-protein complexes 
that regulate metal ions homeostasis and metal cofactors assembly through well-defined 
trafficking routes. Copper(I) trafficking is the most advanced example of how NMR [140] can 
contribute to define the interplay between metal coordination chemistry and protein-protein 
interactions that modulate these fundamental mechanisms. For other metal ions these aspects 
are less explored. Here we will review some key examples involving iron.  
Iron is an essential element: virtually all living organisms require a minimum effective iron 
concentration of 10-8M. The high toxicity of iron(II) associated to its redox activity and the 
extremely low solubility of iron(III) species present under aerobic conditions require that iron 
ions in living systems are found sequestered in high affinity binding proteins. Extracellular iron 
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is bonded to lactoferrin and transferrin, while intracellular iron (when not in functional iron 
sites) is stored in the nanocavity of ferritin as an iron-oxo biomineral. 
Studying proteins involved in iron uptake and storage requires the definition of the 
coordination properties that make them able to bind the metal ion with high affinity albeit 
allowing its release to downstream partners, in response to specific signals. The 
characterization of these novel iron sites has moved the focus of NMR back on the metal 
centers, like it was in the 70’es and 80’es, as at the origin of paramagnetic NMR of iron 
proteins. However, old tools described in 1.2.1 have been flanked by novel approaches, largely 
based on heteronuclear direct detection, now available thanks to recent technological 
advancements [141]. Contemporarily, the definition of the determinants of the protein-protein 
interactions is needed to obtain the complete picture of the process and relies on a new 
chapter of NMR in structural biology. The main aspects of the use of NMR for protein-protein 
interactions will be reviewed below; specific approaches developed for our case systems will be 
discussed in more details in the relevant sections (3.1, 3.2, 3.3).  
NMR and protein interactions. NMR is extensively used to monitor protein interactions in 
solution and to obtain structural information on the resulting adducts. It permits the 
identification of the protein interfaces and, in some cases, provides intermolecular distance and 
orientational restraints that lead to the definition of the relative arrangement of the two 
proteins. In particular, it represents the only structural technique available for studying 
weak/transient protein–protein interactions, but it can be efficiently used also in the case of 
strong/stable complexes. By convention, protein-protein complexes are classified in terms of 
their thermodynamic stability: strong, with dissociation constant Kd for the process  
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< 1 M; weak, with 1 M < Kd < 100 M; ultra weak, with Kd > 100 M [142]. If the recognition 
process occurs as a one-step reaction (a valid assumption in the absence of large 
conformational rearrangement upon complex formation), Kd = koff ⁄ kon, where koff and kon are 
the dissociation and association rate constants, respectively. A wide range of association rate 
constants kon has been measured; they are governed by translational diffusion, which is related 
to the protein size and overall shape, and geometric requirements related to the stereospecific 
nature of protein-protein complexes  (i.e., the two molecules must have appropriate relative 
orientations when they are in contact). In the absence of long-range intermolecular forces the 
typical kon values are of the order of 10
5-106 M-1s-1; when the association process is dominated 
by electrostatic interaction kon values are generally higher, up to 10
10 M-1s-1 [143,144]. 
Diffusion-controlled or electrostatic-guided associations typically involve only local 
conformational changes upon complex formation. When the establishment of an adduct 
involves gross structural changes such as loop reorganization or domain movement, the 
association rate constant decreases and kon values are in the range 10
5> kon >10
3 [143]. The 
dissociation rate constant koff is instead determined by the strength of short range interactions 
between the interacting proteins and measured values fall in a large interval (104-10-7 s-1) 
[145,146]. koff dictates the lifetime of the complex (mean lifetime = 1/koff ; half-life time= 
ln2/koff.) [147]. 
The kinetic aspects of protein-protein interactions are of functional significance: when multiple 
proteins compete for the same partner or when a protein is faced with alternative pathways, 
the kinetic control is often the dominant factor and may serve as an additional mechanism for 
specificity. From the methodological point of view, in NMR kon and koff determine the exchange 
25 
 
rate constant 1M  (Eq. 8; often called kex), which is the crucial parameter for the interpretation 
of the NMR spectra in binding experiments, through the relation [148]: 
kex = kon [A] + koff          (11) 
where [A] is the concentration of the free protein whose spectra are recorded during a titration 
with the partner molecule B. 
If kex >>||, (with  being the chemical shift difference, in frequency unit, for a given signal 
in the free and bound form of A) the system is under the fast exchange regime on the NMR 
chemical shift time scale and the experimental chemical shift value for a given nucleus will 
correspond to the population-weighted average of its chemical shift in the bound and free state 
of the molecule (Fig. 3). Under fast exchange regime, not only the chemical shift, but also all the 
other NMR parameters result population weighted. When kex <<|| (slow exchange regime on 
the NMR chemical shift time scale) two separate signals are observed for the same nucleus, one 
for the bound and one for the free state of A, with relative intensities that correspond to the 
relative concentrations of the two states (Fig. 3). At intermediate exchange regimes, signal 
linewidth is increased due to a phenomenon called “exchange broadening”; such an effect can 
be so severe to broaden the resonance beyond detection (Fig. 3). 
Among the many parameters that can be affected upon complex formation, the chemical shift 
is the most sensitive indicator of protein-protein interactions and the 1H-15N heteronuclear 
single-quantum correlation (HSQC) experiment represents the gold standard for monitoring 
changes in chemical shift involving residues at the protein-protein interface [149,150]. The 1H-
15N HSQC, whenever feasible, is an experiment that with cryoprobe technology can be acquired 
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in a few minutes even for low protein concentrations (down to tens of M) and the resulting 
map is a signature of the protein structure. In binding experiments, the 1H-15N HSQC spectrum 
of one protein in its 15N-enriched form is monitored during the titration with the unlabeled 
interaction partner. The chemical shift perturbations are recorded for each amino acid; 
backbone amide proton chemical shifts are very sensitive probes of variations of the chemical 
environment due to the establishment of the intermolecular interaction and their perturbations 
give rise to measurable effects even in the case of ultra-weak interactions. Provided the 
assignment of the 1H-15N HSQC spectrum is available, shift perturbation measurements identify 
residues of, say, protein A, involved in the interaction with protein B.  The weighted average of 
1H and 15N chemical shift differences of the backbone amide groups of protein A between the 
initial and the final stage of a titration, plotted against the residue number provide the so-called 
Garrett plot [150]. If a structural model of the protein exists, residues undergoing meaningful 
chemical shift perturbations in the Garrett plot are mapped on the protein structure, thus 
identifying the interaction area. The procedure can be repeated using 15N-labeled protein B 
titrated with unlabeled A. Chemical shift perturbation mapping provides the interaction area on 
the individual binding partners, although does not permit the definition of the relative 
orientation of the two molecules nor the atom-to-atom interactions at the basis of the 
recognition process. Residues undergoing chemical shift perturbations can be used as selection 
filters in data driven computational soft-docking programs [151,152]. In the presence of 
binding-induced conformational rearrangements, the chemical shift perturbation may extend 
to residues that are not at the interface, and the chemical shift perturbation fails as a mapping 
tool, although it still represents an excellent indicator of allosteric processes. 
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The presence of a paramagnetic species in at least one of the two interacting proteins is a 
potential source of restraints useful to define the relative orientation of the two proteins, 
provided the paramagnetic effects extend across the interaction surface. The use of inter-
protein PCS has been used for non-functional and functional complexes involving cytochromes 
(ferricytochrome b5/ ferricytochrome c and cytochrome f/plastocyanin, respectively) [153] 
[154]. The use of intermolecular PCS originating from natural heme cofactor suffers for the 
limited range of action (within 20 Å from the iron center) which may not be sufficient for 
complexes larger than those composed by two small electron transfer proteins. These 
limitation has been overcome by introducing on the protein surfaces probes based on caged 
lanthanides containing strongly anisotropic cations such as ytterbium(III) (with the lutetium(III) 
derivative acting as a diamagnetic reference) [155]. 
Paramagnetic Relaxation Enhancements (PRE), based on Eqs. 6 and 7, are another potential 
source of intermolecular structural restraints, due to their r-6 dependence [155,156]. PRE 
effects on the surface of Zn-rubredoxin originating from high spin iron(III) in the interacting 
Desulfovibrio gigas superoxide reductase have been observed up to 5 Å apart from the 
paramagnetic center [157]. More efficiently, caged gadolinium(III) engineered on protein 
surface has been used to monitor protein-protein interactions, leading to the characterization 
of encounter complexes between electron transfer proteins and in particular involving 





3. Case examples 
Here follow three examples of the use of NMR to learn about the bacterial heme acquisition, 
assembly of the FeS cofactors and iron storage. Each of them has required the development of 
ad hoc methodological approaches that take into account the dynamics and the size of the 
systems under investigation. 
3.1 HasA 
Hemophore HasA is a small extracellular protein, with no homology to any other heme binding 
protein, which is part of the Gram-negative Heme acquisition System (HaS). Its function is to 
bind free or heme protein-bound heme and to deliver it to a specific outer-membrane receptor, 
HasR [159]. In vitro, HasA binds heme with a high affinity (Ka= 5.5 × 1010 M-1), while HasR has a 
lower affinity for the heme than HasA (Ka of 5 × 106 M-1), however, it has been shown that 
heme is transferred from its binding site on HasA to its binding site on HasR by a protein-
protein interaction [160].  
As it results from crystal structures [161], in HasA the heme iron(III) ion is bound to an unusual 
pair of axial ligands: a tyrosine (Tyr75) and a histidine (His32). The Tyr75 oxygen forms a tight 
hydrogen bond with the N1 of the neighboring His83, that increases the nucleophilic character 
of Tyr75 and strengthens the Tyr75–iron coordination bond. At variance with the most common 
heme proteins, the two axial ligands (and His83) belong to two loops that connect the  and  
faces of the molecule. These two loops (L1 bearing His32 and L2 bearing Tyr75 and His83) are 
quite mobile in the apo-form of the protein [162] while close as jaws to trap the heme between 
them in the holoprotein [161] (Fig. 4). A major challenge in HasA research was to understand 
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how the peculiar binding site and the structural properties of the protein matrix can induce the 
release from an apparently higher affinity protein to a lower affinity receptor.  
The heme binding site. The 1H heme methyl chemical shift values are diagnostics for the heme 
iron(III) spin state (Section 1.2.1). In HasA, the 1H NMR data suggest the presence of a non-pure 
spin state [163]: the average chemical shift for heme methyls (ca. 40 ppm) is, indeed, 
intermediate between typical values of a purely high-spin, S = 5/2, heme iron(III) and those of a 
purely low-spin, S = 1/2, heme iron(III); the temperature dependence of the chemical shifts of 
these signals shows a nonlinear behavior, in contrast with what predicted by Eq. 1. Newly 
developed 13C direct detection NMR experiments on the wild-type (WT) holoprotein and of 
mutants in which the three key residues of the active site have been replaced by alanine 
[164,165], in combination with traditional bulk magnetic susceptibility measurements in 
solution using the Evans method (see below), provided the key to unravel the nature of the 
peculiar spectral features of the heme center in HasA. 
For any given center with unpaired electrons, paramagnetic relaxation enhancement gives rise 
to a sphere, centered on the metal ion itself, within which NMR signals are broadened, often 
beyond detection, due to the effects arising from Eqs. 4, 6 and 7. The radius of such sphere 
depends on the electron correlation time characteristic of the metal ion, on its spin state, on 
the size of the molecule and on the magnetic field used for the NMR experiment [13]. However, 
it depends also on 2 and therefore, as already discussed in Section 1.2.1, the direct detection 
of 13C spins instead of the conventional 1H detection offers the opportunity to s reduce the 
radius of the “blind sphere” around the paramagnetic center at the expenses of a substantial 
decrease in sensitivity [166].  The availability of high magnetic field spectrometers equipped 
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with specific 13C optimized cryo-probes allows one to circumvent the sensibility problem. 
Actually, all standard 1H detected double and triple resonance experiments have been modified 
and optimized to work in a 13C, protonless, NMR approach [166]. WT-holo HasA represents a 
case in which the complete, 1H, 13C and 15N signals assignment was obtained by a combination 
of standard 1H detected experiments and 13C direct detected experiments [163].  
Monodimensional 13C spectra of holo 13C-enriched HasA (with unlabeled heme) allowed us to 
selectively observe the signals of the axial ligands, which are generally non detectable in 1H 
spectra of iron(III) heme proteins with S>1/2 (Fig. 5)[163]. The temperature dependence of 
their chemical shift unambiguously indicated that the structural basis for the non-pure spin 
state of WT HasA is the release of the axial Y75 ligand upon increasing temperature, which 
leaves a pentacoordinated species or a six-coordinated species with a water molecule as the 
sixth ligand. Upon breaking (or weakening) of the coordination bond between the iron and the 
Tyr, the nuclei of the latter residue would experience no more (or very little) contact shift and 
therefore their shift will tend towards the diamagnetic value, as observed. At the same time, 
the signals of the His32 ligand tend toward larger shifts (in absolute value) as expected for axial 
ligands, when passing from a lower to a higher spin. The H-bond between Tyr75 and H83 has 
been identified as the determinant of the observed change in axial coordination: in the H83A 
mutant the 1H and 13C spectra and their temperature are consistent with a pure high spin 
iron(III) [164]. Monodimensional 13C spectra (Fig.5) have been also the basis of our 
characterization of Y75A and H32A variants of HasA, because the pattern of hyperfine shifted 
resonances permits to identify nature and number of axial ligands while their range of chemical 
shift is diagnostic for the spin state and axial coordination as summarized in Fig. 4 [165]. On the 
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light of the 13C direct detection data, it was possible to better interpret the heme methyls 
patterns of 1H spectra. Spin states and presence of water as an axial ligand had been verified 
using low resolution nuclear magnetic resonance approaches.  
Nuclear Magnetic Resonance Dispersion (NMRD) profiles were the key experiment to observe 
the presence of H2O in the coordination sphere of mutants where only one axial ligand derived 
from a protein amino acid, like in H32A [165]. The Evans method, developed in late 50’s [167], 
is a simple approach that, when applied at the newly available high magnetic fields, gives a very 
sensitive measurement of the spin state of the metal center. The method is based on the 
measurement of the chemical shift of a probe substance due to the bulk magnetic susceptibility 
of a solution containing a paramagnetic species, from which a precise measurement of the 
magnetic moment can be obtained. Evans measurements as a function of temperature have 
allowed us to discriminate between the temperature-dependent HS-LS spin equilibrium in WT 
HasA and the S=3/2 configuration characteristic of the Tyr75/H2O axial coordination in H32A 
[165]. 
Surprisingly, although the presence of axial ligands is crucial for the definition of the heme iron 
spin state, the presence of heme is sufficient to ensure the closed conformation of the two 
loops, even in absence of the corresponding ligand amino acid, thus demonstrating that second 
coordination sphere effects between coordinating water molecules and interactions between 
the porphyrin ring and the protein matrix are stabilizing factors of the closed structure [165]. 
The structure with unbound His32 (as in H32A) and the one whit broken Tyr75-H83 H-bond (as 
in H83A) are also relevant for the definition of functional states of the protein-protein 
complexes that occurs during the heme transfer in the bacterial heme acquisitions system. 
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Heme-mediated protein-protein interactions. In Nature, the hemophore protein HasA cycles 
between two states: the heme-bound holoprotein, which functions as a carrier of the metal 
cofactor toward the membrane receptor HasR, and the heme-free apoprotein fishing for new 
iron-porphyrin to be taken up from the host organism. Heme release and uptake processes 
occur via intermediate states characterized by a Tyr75 iron-bound form with open (non-
binding) conformation of loop L1. In the case of heme release, a further intermediate state has 
been proposed: the displacement of His83 causes the breaking of the hydrogen bond with 
Tys75 and consequent rupture of the coordination bond iron-Tyr. These states do not naturally 
occur in the WT free protein but can only be driven by the interaction with the partner proteins 
[165,168,169], as characterized by NMR . 
Holo and apo-HasA in solution form a stable complex with HasR solubilized in DPC micelles, 
giving rise to a stable supramolecular assembly of about 150 kDa [170]. Residues on HasA 
involved in the interaction with HasR could be identified from 1H-15N CRINEPT-TROSY 
experiments, which have been developed for the “monolateral” chemical shift mapping of 
small/medium sized proteins in complexes up to 1 MDa [171]; the proposed interaction area 
was formed by all signals undergoing changes from their original position in the free form of the 
hemophore. This lead to the identification of a common contact area for both the holo and the 
apo-protein. Further information on the conformation adopted by HasA in the complex was 
derived from the comparison of the 1H-15N fingerprint of all experimentally accessible forms 
(free apo, free holo, complexed holo and complexed apo). The clear outcome of a distance 
matrix analysis of the spectral profiles is that only three conformations are accessible to HasA in 
solution (Fig. 6): that of the isolated holoprotein, that of the isolated apoprotein, and the 
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conformation in the complex. The latter closely resembles that of the apoprotein and is 
independent on the presence of the heme in the starting HasA, as heme in the complex is 
transferred to HasR, with consequent quenching of any paramagnetic effects. 
Hemoglobin (Hb) is the main sources of heme in the host organism. The transient interaction 
between HasA and met-Hb has been studied between the two holo-forms of the proteins [172], 
because using the biologically relevant pair met-Hb/apo-Has the heme transfer is too fast with 
respect to the experimental time. Two interaction areas have been identified on HasA: chemical 
shift perturbations on a fast exchange regime with respect to the NMR chemical shift time scale 
are localized around the axial ligand Tyr75; line broadening effects interpreted in terms of 
conformational exchange involve the L1 loop around His32. The latter effect has proposed to 
originate from  “frustrated attempts at changing the conformation of the His32 loop from 
“closed” to “open” upon sensing the HB surfaces” in this complex where H32 is constrained by 
the coordination bond with the iron in this non-physiological complex.  
 
3.2 FeS assembly 
FeS clusters are probably the oldest and most versatile inorganic cofactors, which can 
participate in electron transfer, catalysis and regulatory processes [41,173,174,175]. Because 
inorganic sulfide and ferrous/ferric iron atoms are toxic in vivo, biosynthesis of FeS proteins 
within cells is a highly regulated process that requires complex protein machineries for the 
mobilization of Fe and S atoms from appropriate sources, for their assembly and their final 
delivery to the recipient proteins  [176,177,178]. In eukaryotic cells, three distinct FeS protein 
machineries are operative: the assembly machinery in the mitochondrial matrix, the export 
34 
 
machinery located in the mitochondrial intermembrane space, and the cytosolic iron–sulfur 
protein assembly (CIA) machinery [179,180]. For proteins involved in these machineries, the 
situation is quite different from that of small electron transfer proteins such as HiPIP and 
ferredoxins (discussed in Section 1.2.1 and 1.2.2), which are always monomeric and rigid, 
thermodynamically very stable and with structural properties tuning the reduction potential of 
each individual iron ion. In contrast, proteins involved into FeS cluster biogenesis are 
characterized by flexible structures and by transient states that are driven by the uptake and 
release of FeS cluster. In these systems the use of old fingerprint approaches for the 
characterization of the metal center, NMR experiments for solution structure determination 
and 1H-15N HSQC for protein-protein interactions come together to provide models of the 
interprotein complexes. 
Anamorsin is a protein identified in human CIA machinery. It is a multidomain protein (312 
amino acids) characterized by a well folded N-Term domain, an unstructured linker of about 50 
aminoacid residues and a C-term region, called CIAPIN1 domain, that binds a [Fe2S2] cluster 
[181]. This protein receives electrons from a diflavin reductase Ndor1 [182]. The electron 
transfer complex between Ndor1 and anamorsin has been monitored via 1H-15N HSQC 
experiments performed upon 15N labeling of one of the two interacting proteins, according to 
the protocol described in Section 2. Specific protein-protein recognition between a completely 
unstructured region involving the linker and part of the C-term of anamorsin and a -helical 
containing face of the FMN binding domain of Ndor1 is observed from these experiments (Fig. 
7) [183]. The formation of the stable complex is independent of the presence of the Fe2S2 
center as well of the redox state of the FMN moiety, indicating that the two partners do 
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interact permanently and no dissociation occurs along the electron transfer process. This 
molecular recognition involves regions that are not in direct contact with the redox cofactors; 
once the complex is formed, the areas surrounding FMN and the Fe2S2 redox centers transiently 
interact indicating that an electron transfer over a short distance is still possible in multiple 
orientation without the requirement to format specific interaction between the two redox 
centers [183], in analogy to the encounter complexes described in Section 2.  
Paramagnetic NMR was fundamental to unravel the structure of the CIAPIN1 domain, the 108-
amino acid C-terminal domain of anamorsin. Indeed, the CIAPIN1 domain is largely 
unstructured and contains paramagnetic Fe2S2 center. About 30% of HN resonances are 
unobserved in a standard HSQC experiment due to the presence of the Fe2S2 center. To identify 
HN resonances from residues within a, roughly, 10 Å distance  from each of the two iron ions, a 
new HSQC experiment has been designed and applied to the isolated CIAPIN1 domain [184]. 
With this approach, thirteen resonances previously unobserved could be identified (Fig. 8), 
assigned and the measured 1H T1 values could be used as restraints to define the protein 
environment of the cluster in the CIAPIN1 domain. 
A similar combination of experiments has been used also to monitor the cluster transfer 
between mitochondrial monothiol Glutaredoxin 5 (Grx5)[185,186], that contains a [Fe2S2] 
cluster, and ISCA1, a iron-sulfur cluster assembly protein that is required for the maturation of 
mitochondrial [Fe4S4] proteins [187,188]. The problem is the understanding, at the molecular 
level, of the transfer of [Fe2S2] from Grx5 to ISCA1. 
Established NMR methods to map protein-protein interactions were consistent with a cluster 
transfer occurring via an associative process involving specific protein-protein interactions. 
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NMR structures and relaxation measurements of apo- and holo Grx5 show that cluster binding 
induces a change of Grx5 quaternary structure passing from an apo monomer to a holodimer 
[189]. Paramagnetic NMR was the only method to identify Grx5 residues belonging to the 
proximity of the cluster. Monodimensional 1H and 13C experiments (Fig 9 A) unambiguously 
showed the presence of two forms of the holoprotein, which are very similar in terms of 
hyperfine contributions to both chemical shift and nuclear relaxation but behave differently 
during the protein-protein interaction. HSQC experiments indicated that one of the two 
holoGrx5 forms is more reactive than the other with respect to transferring the [Fe2S2] cluster 
to apo Isca1. The structural switch between two conformational states observed in holo Grx5 
could be a general mechanism used by monothiol glutaredoxins in FeS assembly pathways(Fig. 
9B), that would permit Grx5 to efficiently release the cluster to multiple protein partners [189]. 
 
3.3 Ferritin 
Ferritins are the main iron storage proteins in eukaryotes and prokaryotes; about 30% of the 
total iron in a healthy human is found stored within ferritin [190,191]. These proteins formed 
by 24 subunits that self-assemble in highly symmetric nanocage architecture, with total 
molecular mass of the order of 480 kDa. The protein shell surrounds a central cavity that 
occupies about 1/3 of the total volume of the molecule and which can store up to 4500 iron 
atoms in the form of a ferric-oxo mineral. The sequence of the subunits varies from one 
organism to another and, in eukaryotes, one ferritin molecule may be formed by multiple types 
of subunits. All subunits, however, share a 4-helix bundle structure completed, on one side of 
the bundle, by a short C-terminal helix H5. (Fig. 10). The symmetry of the overall architecture 
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derives from i) extended intersubunit contacts involving pairs of helices with head-to-tail 
relative orientation (C2 symmetry axes), ii) contacts among the H5 helices of 4 different 
subunits that create 6 pores with C4 symmetry and iii) contacts among 3 subunits that come 
together via the side of the bundle opposite to the H5 helix to form 8 ion channels with C3 
symmetry.  
The overall reaction occurring in ferritin is [191]: 
2Fe2+ + O2 + (H2O)x+3  Fe2O3(H2O)x + 4H
+ + H2O2 
In practice, it proceeds through a multisetp process that requires iron(II) entering the protein 
shell, reaching the active center of catalytic subunits, where it is oxidized to diferric iron 
products, and then migrating towards the nanocavity to generate the biomineral, that is 
released in response to specific stimuli. The X-ray structure of the protein part is known at high 
resolution for ferritins from many organisms [192,193,194], but the interaction mode of iron 
with the protein was not defined until very recently, with an important contribution from NMR 
[195]. 
There are several unanswered or only-partially answered questions in ferritin chemistry: The 
interactome of ferritin is largely unknown. Human Poly r(C)-Binding Proteins 1-3 (PCBP1-3) have 
been proposed to function as cytosolic iron chaperones in the delivery of iron to ferritin [196], 
and direct interactions between the chaperons and ferritin have been recently reported on the 
basis of ITC experiments [197]. There are no evidences that a protein-protein interaction is at 
the basis of the iron release from the biomineral, although it’s known that synthetic peptides 
may facilitate the process [198].  
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The role of C4 pores is not well-understood. They have a hydrophobic surface and contain 
residue that, in crystal structures, are shown to interact with metal ions [199], but the available 
variants with mutations of such residues do not show significantly different iron uptake and 
only slightly different iron release [200]. On the contrary, negatively charged residues in the C3 
pores have a crucial role in iron uptake, as shown by mutation studies where Asp and Glu 
binding metal cations in X-ray structures have been substituted with hydrophobic side chains 
[200,201,202,203]. Unfolding of the C3 pores facilitates iron release [204,205]. 
The mechanism of the catalytic reaction occurring at ferritin active is still matter of debate. The 
subunits of prokaryotic ferritins and the so-called H and M subunits of eukaryotic ferritin are 
catalytically functional: upon addition of iron(II) in ferritin solution a diferric-peroxo (DPF) 
intermediate forms (with typical absorbance at 650 nm) and quickly evolves into ferric-oxo 
species (monitored at 350 nm) [206]. Based on these observations it had been proposed that 
two ferrous ions react with O2 at the catalytic site forming the DPF intermediate and 
immediately after transform in diferric-oxo dimers that migrate towards the nanocavity to form 
the biomineral, leaving an empty active site that would be ready to host two new incoming 
iron(II) ions in a subsequent reaction turnover [207]. X-ray structure solved in the presence of 
redox-inactive divalent cations such as zinc(II) and magnesium(II) where taken as models of the 
ferrous-bound precursors; small differences in the coordination sphere where interpreted as 
the key to determine whether the Fe-active site bonds persist throughout the reaction cycle (in 
diiron enzymes, where iron is the catalytic center) or break to release diferric oxo products (in 
ferritin, where iron(II) is the reaction substrate) [208].  
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This was the generally accepted scenario when we decided to study the ferritin reaction by 
NMR. Structure-function relationships can be derived from NMR experiments only if at least a 
partial NMR assignment of the protein spectra is available. The ferritin size prevents the use of 
standard solution NMR approaches for sequence specific assignments; as detailed in references 
[195,209].1H NMR lines for slow tumbling molecules above 100 kDa are prohibitively large for 
triple resonance experiments. 13C NMR spectra have a better resolution, at least for aliphatic 
and C nuclei, but assignment strategies based on protonless pulse sequences also failed due 
to the short transverse relaxation times that do not allow efficient coherence transfer in J-
coupled experiments. On the other hand 13C-13C NOESY maps allowed the detection of well 
resolved spin-patterns for most of the amino acid side chains, thus constituting an ideal starting 
point for monitoring the reaction between the protein and partner molecules/ions in solution 
[210,211]. We therefore developed a combined solution/solid state NMR approach in which 
solid state NMR experiments of ferritin microcrystals were successful to obtain sequence 
specific assignments, which then could be used to exploit solution state 13C-13C NOESY maps 
(Fig. 11) [209]. This was the basis for the characterization of the ferritin-iron interaction in 
solution. Iron was added with a stoichiometry of two iron(II) ions per ferritin subunit and the 
obtained 13C-13C NOESY map was compared with that of the apoprotein: according to the 
common beliefs we would have expected to observe signal broadening due to paramagnetic 
effects arising from the diferric-oxo products inside the nanocavity. Instead paramagnetic 
broadening beyond detection was observed for residues in the middle of the 4-helix bundle 
channel in the proximity of the magnesium/zinc binding sites (Fig. 12 A and B) [209]. The two 
ferric ions are antiferromagnetically coupled with apparent effective magnetic moment of 4.5 
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μB, as measured by Evans experiments.[209] The expected paramagnetic broadening in a 480 
kDa protein at high magnetic field is dominated by the Curie relaxation (Eq. 7) and is expected, 
at 16.4 T, to broaden beyond detection residues within about 5 Å from the metal ions. Using 
the signals of assigned isoleucine residues (which are well resolved in 13C-13C NOESY and 
strategically distributed in the protein structure) as probes of the location of the paramagnetic 
species we could establish that the diferric products remains stably bound at the catalytic 
center after the oxidation reaction as occurred and that the binding site is close but not 
coincident with that of the redox inactive cations observed in the X-ray structures [209]. To 
further confirm this result that was contrasting previous views, we have solved the X-ray 
structures of iron-loaded ferritin crystals obtained by soaking crystals in FeSO4 solutions 
followed by flash freezing: the binding site of diferric species was thus unequivocally defined 
(Fig. 12 C) [199], although a debate is still open on the mechanism the ferric ions are replaced 
by new incoming iron(II) species in subsequent turnovers [195,212,213]. The pathway guiding 
the ferric products formed at the active site towards the cavity need to be precisely defined. 
NMR titrations of ferritin with iron were conducted with subsequent additions of iron(II) in 
steps of two ions/subunit (up to 8 irons/subunit). While the paramagnetic effects observed in 
13C-13C NOESY with the first two irons/subunit persist, the number of signals broadened beyond 
detection increases at each step, with affected residues located between the active site and the 
H5 helix, toward the C4 pore (Fig. 12 B) [209]. The obvious interpretation of these data is as 
follows: new incoming iron(II) ions substitute the di-iron(III) moiety at the catalytic site and are 
oxidized in subsequent turnovers; the ferroxidase center is always occupied by iron; a push-pull 
mechanism induced by the new ferrous iron forces the leaving diferric products to proceeds 
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towards the nanocavity through a pathway involving residues between the active site and the 
C4 term of the bundle. Evans measurements suggested antiferromagnetic coupling between 
subsequently formed diferric products that probably generate increasingly larger clusters [209]. 
The latter mechanism still waits to be proved by higher resolution data. 
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Fig. 1.  The first solution structure of a paramagnetic protein: family of the 15 best structures 
of the reduced form of high-potential iron-sulfur protein I from Ectothiorhodospira 
halophila, containing a [Fe4S4]
2+ cluster [110]. 
Fig. 2.   First application of PCS for structural refinement: the solution structure of the cyanide 
adduct of Ala80cytochrome c determined via NOE-based upper distance limits (top 
panel) has been refined using PCS restraints (lower panel) taking advantage of the 
large magnetic susceptibility anisotropy of the low spin heme-iron(III) center  [121]. 
Fig.3.   Exchange regimes on the chemical shift NMR time scale in binding experiments. When 
a nucleus experience two distinct chemical environments in the free and bound form 
of a molecule, different situations are possible depending on the relative value of kex 
and on the difference in chemical shift (expressed in frequency units) of the two 
forms. When passing from the slow (top trace) to the fast exchange (bottom trace), 
we observe signal broadening and coalescence into a single resonance. 
Fig. 4.   The holo HasA structure and the heme binding module in WT and mutants. Top left: 
the ribbon representation of the protein structure highlights the segregated  
(magenta) and  (orange) regions, loop L1 bearing the H32 axial ligand (green), loop L2 
(bearing the axial ligand Y75 and the H-bonded H32; both cyan); the heme is 
represented by ball-and-sticks. Top-right: the spectroscopic features of WT holoHasA 
are consistent with a thermally-dependent equilibrium between a low-spin and a high-
66 
 
spin form. Bottom, from left to right: axial coordination and spin state at neutral pH of 
Y75A, H83A and H32A.  
Fig. 5.   Monitoring the axial ligation of HasA variants by 13C NMR. The monodimensional 13C 
NMR spectra of WT HasA and its mutants reflect the difference in the number of axial 
ligands provided by protein amino acids (number of detectable resonances) and spin 
state (chemical shift range). 
Fig. 6.  NMR fingerprint of HasA conformations. 1H-15N spectral fingerprint of holo and 
apoHasA in their free form and when bound to HasR have been analyzed using a 
distance matrix approach. Three main conformations have been observed and here 
indicated by three different colors: the open form of apoHasA (dark green), the closed 
form of holoHasA (brownish red), and a common complexed form (light green). The 
latter is much closer to that of apoHasA (0.54/0.55) than to the holoHasA (1.00). The 
numbers are the results of the statistical spectral comparison; a value of zero 
corresponds to identity while an index on 1 is attributed to the pair resulting in the 
largest difference. 
Fig. 7.  Binding interface of the FMN-binding domain of Ndor1 interacting with [Fe2S2]-
anamorsin. Residues experiencing chemical shift and line broadening variations upon 
interaction are indicated with spheres. Chemical shift changes occurs at the Ndor1 
regions involved in the encounter complex with anamorsin, line broadening effects 
are observed as a consequence of the proximity of the paramagnetic [Fe2S2] center. 
Large blue spheres: residues showing large chemical shift changes and characterized 
by relative solvent accessibility above 50%. Small blue spheres: residues showing large 
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chemical shift changes but featuring relative solvent accessibility lower than 50%. 
Large cyan spheres: residues showing small chemical shift changes with concomitant 
broadening effects and with relative solvent accessibility above 50%. Small cyan 
spheres: residues showing small chemical shift changes with concomitant broadening 
effects and with relative solvent accessibility lower than 50%. Positively charged 
(gray), negatively charged (red), and hydrophobic (yellow) side chains which are highly 
solvent exposed in the interacting region are also indicated [183]. 
Fig. 8.  Selective observation of paramagnetic signals in 1H-15N spectra of the [Fe2S2]
2+-
CIAPIN1 domain. The standard HSQC spectrum (red) is overlaid with the 
paramagnetic-tailored analogue (black) allowing to selectively observe signals from 
HN close in space to the paramagnetic center which usually escape detection in an 
standard experiment [184].  
Fig. 9.  NMR has been used to learn about the mitochondrial transfer of the [Fe2S2] cluster 
from monothiol Glutaredoxin 5 (Grx5) to apoISCA1. (A) 1D 13C NMR spectrum showing 
the iron binding cysteines in holo Grx5. The 13C T1 values of the identified CO and C signals 
are reported. (B) Scheme of the proposed transfer mechanism.  
Fig. 10.  Key structural elements of the ferritin nanocage. Top left: the subunits have a 4-helix 
bundle structure completed by a short helix at the C-term. Top right: pairs of subunit 
have extended contacts along C2 symmetry axes. Bottom left: C3 symmetry axes from 
where three subunits come in contact and form ion channels. Bottom right: C4 
symmetry axes form when 4 subunits come in contact via their short C-term helices, 
creating hydrophobic channels. (Designed using PDB id 1MFR). 
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Fig. 11.  Combined solution/solid state NMR approach for ferritin. Partial sequence specific 
assignment of ferritin spectra could be achieved via solid state NMR approaches and 
then transferred to solution spectra; the process was possible because the 13C-13C 
correlation maps in solution (blue) and solid state (red) are superimposable [209].  
Fig. 12.  Iron binding to ferritin. (A) The binding of iron to ferritin was monitored via solution 
13C-13C NOESY [209]: when 2 iron/subunit are added (red trace) paramagnetic 
broadening beyond detection with respect to the apo form (black trace) is observed 
for a few signals (for example A26 and I144). (B) Paramagnetic effects at different 
stage of the titration with iron are mapped (red spheres) on the subunit structure. (C) 
The X-ray structure solved later on shows the di-ferric binding site which is fully 








Brief history of paramagnetic NMR of iron sites in proteins 
Application of NMR to protein-protein interactions 
New NMR tools permit the fingerprinting of binding modules in transient iron sites 
Trafficking of iron cofactors is mediated by protein-protein interactions 
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